| Literature DB >> 35324602 |
María García-Montero1, Gema Felipe-Márquez2, Pedro Arriola-Villalobos2, Nuria Garzón1.
Abstract
This review has identified evidence about pseudomyopia as the result of an increase in ocular refractive power due to an overstimulation of the eye's accommodative mechanism. It cannot be confused with the term "secondary myopia", which includes transient myopic shifts caused by lenticular refractive index changes and myopia associated with systemic syndromes. The aim was to synthesize the literature on qualitative evidence about pseudomyopia in terms that clarify its pathophysiology, clinical presentation, assessment and diagnosis and treatment. A comprehensive literature search of PubMed and the Scopus database was carried out for articles published up to November 2021, without a data limit. This review was reported following the preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines. Following inclusion and exclusion criteria, a total of 54 studies were included in the qualitative synthesis. The terms pseudomyopia and accommodation spasm have been found in most of the studies reviewed. The review has warned that although there is agreement on the assessment and diagnosis of the condition, there is no consensus on its management, and the literature describes a range of treatment.Entities:
Keywords: accommodation; accommodation spasm; pseudomyopia; refractive error
Year: 2022 PMID: 35324602 PMCID: PMC8950661 DOI: 10.3390/vision6010017
Source DB: PubMed Journal: Vision (Basel) ISSN: 2411-5150
Inclusion and exclusion criteria.
| Inclusion Criteria |
|---|
| Pseudomyopia caused by an increase in ocular refractive power due to overstimulation of the eye’s accommodative mechanism. |
| Explicit mention of pseudomyopia as the primary outcome reported. |
|
|
| Not related to subject interest. |
| Reported secondary myopia. |
| Reported pseudomyopia, but it is not the primary outcome. |
Figure 1PRISMA flow diagram.
Summary of the clinical features of the reviewed cases reports.
| Author | Sex | Age | Symptoms/Signs | Diagnostic Test | Non-Cycloplegic Rx (D) | Cycloplegic Rx | Gap Refraction (D) | Dx/Etiology | Treatment | After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|
| Rutstein, Marsh-Tootle 2001 [ | Female | 27 | Blurred distance vision in LE | VA | RE plano | RE + 0.75 − 0.25 × 180 | RE 0.75 | Pseudomyopia | Not treatment | Not reported |
| Ninomiya et al. 2003 [ | Male | 12 | Blurred distance vision after a head/eye trauma soccer ball | VA | RE −2.00 | RE plano | RE 2.00 | Pseudomyopia | Cyclopentolate 0.1%, 2 drops/day | Resolved |
| Ninomiya et al. 2003 [ | Female | 37 | Blurred distance vision | VA | RE −11.25 | RE −3.50 | RE 7.75 | Pseudomyopia | Not reported | Not reported |
| Peinado et al. 2019 [ | Female | 10 | Monocular decreased of vision | VA | RE −6.00 | RE +0.50 | RE 6.50 | Pseudomyopia | Atropine 1% daily (15 days) and +3D near-vision spectacles in RE | Resolved |
| Hughes et al. 2017 [ | Female | 34 | Blurred distance vision in RE after a whiplash injury sustained | VA | RE −3.50 | Not reported | Pseudomyopia | Far vision minus lens | Not resolved | |
| Laria et al. 2014 [ | Female | 8 | Headaches and blurred vision | VA | RE −9.75 − 0.25 × 65°LE −7.75 − 0.75 × 65° | RE +0.75 | RE 10.50 | Pseudomyopia | Cyclopentolate 1.0%, 2 drops/day Atropine 1%, 1 drop/day and near-vision glasses. | Resolved |
| Shetty et al. 2015 [ | Female | 33 | Blurred distance vision and headache after one month PRK for myopia | VA | RE −0.75 − 0.50 × 165° | RE −0.50 × 165 | RE −0.75 | Pseudomyopia | Cyclopentolate 1%, 3 drops/day | Resolved |
| Airiani S, Braunstein RE 2006 [ | Female | 41 | Severe headache after undergoing | VA | RE −2.25 − 0.50 × 170° | RE plano | RE 2.25 | Pseudomyopia | Cyclopentolate 1% | Patient lost to follow-up |
| Shanker et al. 2012 [ | Male | 22 | Headaches and blurred vision | VA | RE −10.00 D | RE −2.25 | RE 7.75 | Pseudomyopia | Homatropine 2%, 2 drops/day for 10 days | AS resolved, but after exotropia intermittent |
| Jayakumar et al. 2012 [ | Male | 29 | Squint and blurred vision | VA | Not reported | RE plano | Basic exotropia | Bilateral | Blurred vision after strabismus surgery | |
| Blurred vision after strabismus surgery | VA | RE −2.00 − 0.50 × 90° | RE plano | RE 2.25 | Pseudomyopia | Cyclopentolate 1%, 3 drops/day | Not reported | |||
| Bohlmann BJ, France TD 1987 [ | Female | 19 | Blurred distance vision after trauma | VA | RE −1.50 | RE 0.25 | RE 1.75 | Pseudomyopia after a closed head trauma | Atropine 1% and bifocals | Resolved after 9 years |
| London et al. 2003 [ | Female | 15 | Blurred distance vision after closed head trauma | VA | RE −1.50 | RE +0.50 | RE 2.00 | Pseudomyopia | Accommodative rock exercises | Resolved |
| London et al. 2003 [ | Male | 25 | Blurred distance vision for a year. | VA | RE −2.75 | RE −0.50 | RE 2.25 | Pseudomyopia | Accommodative rock exercises | Partially resolved |
| London et al. 2003 [ | Female | 36 | Blurred and variable distance vision after closed head trauma.Pupillary asymmetry | VA | RE −1.50 − 1.00 × 175° | RE −0.25 | RE 1.25 | Pseudomyopia | Homatropine 5% | Partially resolved |
| London et al. 2003 [ | Male | 17 | Blurred distance vision without correction and blurred near vision with correction unilateral for a year after head trauma | VA | LE −2.25 | LE −0.25 | LE 2.00 | Pseudomyopia | Bifocal glasses | Partially resolved |
| Chan RV, Trobe JD 2002 [ | Male | 30 | Blurred distance vision after trauma | VA | RE −1.50 | RE plano | RE 1.50 | Pseudomyopia after a closed head trauma | Manifest Rx | Not resolved |
| Male | 20 | RE −5.00 | RE −3.25 | RE 1.75 | Manifest Rx | Not resolved | ||||
| Male | 18 | RE −1.50 − 0.75 × 93° | RE +0.75 − 1.50 × 90° | RE 1.50 | Cycloplegic Rx | Not resolved | ||||
| Male | 17 | RE −2.50 − 0.50 × 10° | RE −1.00 − 0.25 × 10° | RE 1.50 | Homatropine and bifocals | Not resolved | ||||
| Male | 16 | RE −2.00 | RE −1.25 | RE 0.75 | Manifest Rx | Not resolved | ||||
| Mc Murray et al. 2004 [ | Male | 28 | Decreased VA after closed head trauma sustained in a motor vehicle accident 16 weeks earlier | VA | NR | NR | RE 4.00 | Pseudomyopia | Unsatisfactory | Resolved |
| Park et al. 2021 [ | Female | 33 | Blurred distance vision after | VA | RE −2.34 (SE) | RE −0.26 (SE) | RE 2.08 | Pseudomyopia with paradoxical accommodation | Glasses −1.00 D | She is in monitorization |
| Nguyen et al. 2020 [ | Female | 10 | Painless vision loss in both eyes | VA | RE −8.50 − 0.50 × 57° | RE +0.75 − 0.50 × 7° | RE 9.25 | Accommodative spasm associated with conversion disorder | Atropine 0.5%–0.1%–0.01% in both eyes once daily-10 weeks | Atropine drops discontinued |
D: diopter; Dx: diagnosis; SE: spherical equivalent; NR: not reported; VA: visual acuity; RE: right eye; LE: left eye; Gap refraction: difference between cycloplegic and non-cycloplegic refraction; OCT: optical coherence tomography; MRI: magnetic resonance imaging; NRA: negative relative accommodation; SA: Spherical aberration; MEM: Monocular Estimation Method to measure accommodative response. * Spherical aberration measured by Hartmann-Shack wavefront aberrometer in central 4-mm zone. † Aberrometry measured by iTrace Visual Function Analyzer; Tracey Technologies.
Historical evolution of treatments.
| Author | Year | Cycloplegic Agents | Plus Lenses | Manifest Rx | Prism Base in | Orthoptics |
|---|---|---|---|---|---|---|
| Shaffer [ | 1928 | x | x | |||
| Padman [ | 1930 | x | ||||
| Hathaway [ | 1930 | x | ||||
| Willians [ | 1956 | x | ||||
| Bohlmann BJ, France TD [ | 1987 | x | x | |||
| Ciufreda [ | 1999 | |||||
| Chan RV, Trobe JD [ | 2002 | x | x | x | ||
| Ninomiya et al. [ | 2003 | x | ||||
| London et al. [ | 2003 | x | x | x | x | |
| Airiani S, Braunstein RE [ | 2006 | x | ||||
| Shanker et al. [ | 2012 | x | x | |||
| Jayakumar et al. [ | 2012 | x | x | |||
| Laria et al. [ | 2014 | x | x | x | ||
| Shetty et al. [ | 2015 | x | ||||
| Hughes et al. [ | 2017 | x | x | |||
| Peinado et al. [ | 2019 | x | x | |||
| Nguyen et al. [ | 2020 | x | ||||
| Park et al. [ | 2021 | x |